Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
1. Rescheduling cannabis could allow WBA to sell cannabis products. 2. FDA oversight demands higher production standards for cannabis businesses. 3. Interstate commerce may revolutionize cannabis supply chains. 4. Potential M&A activity triggered by compliance challenges. 5. Political factors could delay cannabis rescheduling process.